ARCHIVES

Phase III Trial Would Give Clearer Picture Of C225 Role.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of November

November 29, 2013

Institute of Medicine Elects 80 New Members

October 24, 2014

FDA Proposes To Require Electronic Submission

May 3, 2002

Weicker Compromise on 6,000 Grants For Two Years Holds Up; New Waxman Bill Would Renew Cancer Act

May 17, 1985

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006